Innovita Biological Technology Co., Ltd. (SHA:688253)
China flag China · Delayed Price · Currency is CNY
53.69
+0.92 (1.74%)
At close: May 12, 2026

SHA:688253 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
323.87422.03621.39478.02446.62326.91
Revenue Growth (YoY)
-40.76%-32.08%29.99%7.03%36.62%-68.48%
Cost of Revenue
-9.22-127.53140.51173.9477.24
Gross Profit
333.09422.03493.86337.51272.67249.67
Selling, General & Admin
-6.73-149.6299.1190.8483.96
Research & Development
-16.49-97.1753.1172.1831.11
Other Operating Expenses
260.45261.513.011.448.892.87
Operating Expenses
234.66261.51253.83158.57178.08117.58
Operating Income
98.43160.53240.03178.9494.59132.09
Interest Expense
-3.96--0.11-0.2-0.41-0.13
Interest & Investment Income
--30.7424.5712.113.59
Currency Exchange Gain (Loss)
--1.140.5742.65-9.76
Other Non Operating Income (Expenses)
-0.540.1-3.920.34-0.6-0.11
EBT Excluding Unusual Items
93.93160.62267.87204.22148.35125.68
Gain (Loss) on Sale of Investments
0.59-7.469.152.230.89
Gain (Loss) on Sale of Assets
---0.1-0.010.01-
Asset Writedown
0.39---19.54--0
Other Unusual Items
--1.294.5413.9211.24
Pretax Income
94.91160.62276.53198.36164.51137.81
Income Tax Expense
3.5214.5829.6724.4113.8217.65
Earnings From Continuing Operations
91.39146.04246.86173.95150.68120.16
Minority Interest in Earnings
-----0.09
Net Income
91.39146.04246.86173.95150.68120.25
Net Income to Common
91.39146.04246.86173.95150.68120.25
Net Income Growth
-53.39%-40.84%41.92%15.44%25.31%-78.96%
Shares Outstanding (Basic)
136136136136122102
Shares Outstanding (Diluted)
136136136136122102
Shares Change (YoY)
0.02%0.08%0.36%11.83%19.24%2.90%
EPS (Basic)
0.671.071.811.281.241.18
EPS (Diluted)
0.671.071.811.281.241.18
EPS Growth
-53.40%-40.88%41.41%3.23%5.08%-79.55%
Free Cash Flow
--269.31242.8968.7142.52
Free Cash Flow Per Share
--1.981.790.560.42
Dividend Per Share
--0.5600.4000.166-
Dividend Growth
--40.00%140.96%--
Gross Margin
102.85%100.00%79.48%70.60%61.05%76.37%
Operating Margin
30.39%38.04%38.63%37.43%21.18%40.41%
Profit Margin
28.22%34.61%39.73%36.39%33.74%36.79%
Free Cash Flow Margin
--43.34%50.81%15.38%13.01%
EBITDA
-179.22258.72200.92111.08145.29
EBITDA Margin
-42.47%41.64%42.03%24.87%44.45%
D&A For EBITDA
-18.718.721.9816.4913.21
EBIT
98.43160.53240.03178.9494.59132.09
EBIT Margin
30.39%38.04%38.63%37.43%21.18%40.41%
Effective Tax Rate
3.71%9.08%10.73%12.31%8.40%12.80%
Revenue as Reported
--621.39478.02446.62326.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.